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Background: Vaccination is the key measure available for prevention of the public health burden of annual
influenza epidemics. This article describes national trends in seasonal influenza vaccine (IV) coverage in Portugal
from 1998/99 to 2010/11, analyzes progress towards meeting WHO 2010 coverage goals, and addresses the effect
of major public health threats of the last 12 years (SARS in 2003/04, influenza A (H5N1) in 2005/06, and the
influenza A (H1N1)2009 pandemic) on vaccination trends.
Methods: The National Institute of Health surveyed (12 times) a random sample of Portuguese families. IV coverage
was estimated and was adjusted for age distribution and country region. Independence of age and sex coverage
distribution was tested using a modified F-statistic with a 5% significance level. The effect of SARS, A (H5N1), and
the A (H1N1)2009 pandemic was tested using a meta-regression model. The model was adjusted for IV coverage in
the general population and in the age groups.
Results: Between 1998/99 and 2010/11 IV, coverage in the general population varied between 14.2% (CI 95% :
11.6%–16.8%) and 17.5% (CI 95% : 17.6%–21.6%). There was no trend in coverage (p = 0.097). In the younger age
group (<15 years) a declining trend was identified until 2008/09 (p = 0.005). This trend reversed in 2009/10. There
was also a gradual and significant increase in seasonal IV coverage in the elderly (p for trend < 0.001). After 2006/07,
IV coverage remained near 50%. Adjusting for baseline trends, there was significantly higher coverage in the
general population in 2003/04 (p = 0.032) and 2005/06 (p = 0.018). The high coverage observed in the <15-year age
group in season 2009/10 was also significant (p = 0.015).
Conclusions: IV coverage in the elderly population displayed an increasing trend, but the 75% WHO 2010 target
was not met. This result indicates that influenza vaccination strategy should be improved to meet the ambitious
WHO coverage goals. The major pandemic threats of the past decade had a modest but significant effect on
seasonal influenza vaccination. There was an increase in vaccine uptake proportion in the general population in
2003/04 and in 2005/06, and in individuals <15 years old in 2009/10.
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The public health burden of annual influenza epidemics
represents ongoing vulnerability to pandemic influenza
and highlights gaps in bioterrorism preparedness and re-
sponse efforts [1,2]. The recent emergence of the pan-
demic influenza A (H1N1) 2009 virus is a good example
of how influenza can impact health systems around the
world [3].
Currently, vaccination is the key measure available for
prevention of influenza and associated complications.
Strategies that focus on providing routine vaccination to
persons at higher risk for influenza complications have
long been recommended, although coverage among
most of these groups remains low [4]. Concurrently,
there is a need to increase seasonal vaccine use through
clear immunization policies as a way to stimulate indus-
try to boost production capacity [5].
During the 2009/10 season, the influenza pandemic
led to reinforcement of influenza vaccination recom-
mendations in European countries, including Portugal.
The pandemic also led to renewed interest in influenza
vaccination surveillance.
Continued annual monitoring is needed to determine
the effects of vaccine supply, changes in influenza vac-
cination recommendations, changes in groups targeted
for vaccination, and other factors, on vaccination cover-
age among adults and children [4]. Vaccine coverage
rates constitute the basic measure for evaluation of pub-
lic health programs designed to improve vaccination up-
take and for estimation of how the vaccination program
affects the rate of disease.
Circumstantial factors (e.g., personal reasons) may
affect the rate of vaccination [6]. In the last 12 years
three major pandemic threats, not all caused by influ-
enza virus, affected public and healthcare professionals’
perceptions of the need for influenza vaccine (IV) uptake.
These pandemic threats were severe acute respiratory syn-
drome (SARS) in 2003, “avian influenza” (influenza A
(H5N1)) in 2005, and the recent influenza A (H1N1)2009
pandemic. The rapid worldwide dissemination of SARS in
2003 was a rehearsal for the next influenza pandemic [7].
In 2005, the World Health Organization (WHO) declared
that the emergence and persistence of influenza A (H5N1)
in birds and the associated human fatalities were a public
health threat and fostered early response strategies to con-
tain the pandemic [8]. In April 2009, the spread of novel
swine flu origin influenza A (H1N1) prompted the declar-
ation of a pandemic by WHO in June of the same year [9].
Whether this raised awareness had a positive or negative
effect on IV uptake varies according to country and to
situation [6,10,11].
Every year, based on surveillance of clinic and laboratory
data provided by a global network of Influenza Surveillance
Centers, the WHO recommends the composition of thevaccine that will be used the next season [12]. The General
Directorate of Health (DGS) in Portugal issues an informa-
tion guide to Ministry of Health and private sector doctors
in September/October of each year. The guide describes
vaccine specifications for the current season and indica-
tions for vaccine uptake. Each flu season, the main object-
ive of the DGS has been to increase IV coverage in high
risk groups (i.e., individuals >65 years old and patients with
specific chronic diseases) and priority groups of health pro-
fessionals [13,14]. Table 1 describes how the recommenda-
tions have changed over time.
In 2004, WHO established a 75% IV coverage target in
the elderly (>65 years) that was in effect until 2010 [12].
In 2006, DGS established an interim target of 50% vac-
cine coverage among individuals aged 65 years and over
for the 2006/07 season [14].
Despite the occurrence of a pandemic due to a new
strain of influenza virus in 2009, the DGS has main-
tained the same seasonal IV recommendations for the
major risk groups [15]. Concurrently, the recommenda-
tion expanded to include vaccination against pandemic
influenza A (H1N1) 2009 for children from 6 months to
12 years. Older individuals were included only if they
had a specific chronic disease [16].
Since the 1998/99 season, the Department of Epidemiology
(DEP) of the National Institute of Health Doctor Ricardo
Jorge (INSA; previously the National Health Observatory
(ONSA)) has monitored IV coverage. This system is the
only one in the country that estimates IV coverage in the
general Portuguese population and in subgroups. This in-
formation cannot be obtained from a count of vaccine
sales or from vaccine administration data.
This article describes national trends in seasonal IV
coverage in Portugal from 1998 and 2010 in the general
population and in age groups presents an analysis of
progress towards WHO 2010 coverage goals. It also ad-
dresses the effects of the major pandemic threats (SARS
in 2003, influenza A (H5N1) in 2005, and the influenza
A (H1N1)2009 pandemic) on vaccination trends for the
last 12 years.
Methods
Between 1998/99 and 2010/11, INSA conducted 12
household telephone surveys using a panel of families
(ECOS – Em Casa Observamos Saúde/Observing Health
at Home). These surveys were used to collect data on IV
coverage in the mainland Portuguese population.
The ECOS panel consisted of a random sample of
Portuguese families with a landline telephone and of fam-
ilies with landline and mobile phone since the 2009/10
sample (dual sample frame). The sample was stratified
and was evenly distributed to represent the five health re-
gions of the country. Landline phone households were se-
lected by simple random selection from the national
Table 1 Recommendations for seasonal influenza
vaccination in Portugal, 1998/99 to 2010/11 seasons
Season Recommendation for seasonal influenza vaccination
1998/00 Not available
2001/02 Elderly
Individuals (>6 months) with chronic diseases and high-risk
conditions
2002/03 Elderly
Individuals (>6 months) with chronic diseases and high-risk
conditions
Healthcare workers
Contacts of persons at high risk
2003/04 Elderly
Residents of institutions for the elderly and the disabled
Individuals (>6 months) with chronic diseases and high-risk
conditions, including pregnant women
Homeless
Healthcare workers
Contacts of persons at high risk
2004/05 Elderly
Residents of institutions for the elderly and the disabled
Individuals (>6 months) with chronic diseases and high-risk
conditions, including pregnant women
Homeless
Healthcare workers
Contacts of persons at high risk
2005/06 Elderly
Residents of institutions for the elderly and the disabled
Individuals (>6 months) with chronic diseases and high-risk
conditions, including pregnant women
Homeless
Healthcare workers
Contacts of persons at high risk
Women in the 2nd and 3rd trimester of pregnancy
Professionals that may be involved in culling poultry
infected with influenza virus
2006/07 Elderly
Residents of institutions for the elderly and the disabled
Individuals (>6 months) with chronic diseases and high-risk
conditions, including pregnant women
Healthcare workers
Contacts of persons at high risk
Women in the 2nd and 3rd trimester of pregnancy
Professionals that may be involved in culling poultry
infected with influenza virus
2007/08 Elderly
Residents of institutions for the elderly and the disabled
Individuals (>6 months) with chronic diseases and high-risk
conditions, including pregnant women
Table 1 Recommendations for seasonal influenza
vaccination in Portugal, 1998/99 to 2010/11 seasons
(Continued)
Healthcare workers
Contacts of persons at high risk
Women in the 2nd and 3rd trimester of pregnancy
Professionals that may be involved in culling poultry
infected with avian influenza virus
2008/09 Elderly
Residents of institutions for the elderly and the disabled
Individuals (>6 months) with chronic diseases and high-risk
conditions, including pregnant women
Healthcare workers
Contacts of persons at high risk
Women in the 2nd and 3rd trimester of pregnancy
Professionals that may be involved in culling poultry
infected with avian influenza virus
2009/10* Elderly
Residents of institutions for the elderly and the disabled
Individuals (>6 months) with chronic diseases and high-risk
conditions, including pregnant women
Healthcare workers
Contacts of persons at high risk
Women in the 2nd and 3rd trimester of pregnancy
2010/11 Elderly
Residents of institutions for the elderly and the disabled
Individuals (>6 months) with chronic diseases and high-risk
conditions, including pregnant women
Healthcare workers
Contacts of persons at high risk
Women in the 2nd and 3rd trimester of pregnancy
Source: General-Directorate of Health, Recommendations for seasonal influenza
vaccine, Information Guide, 2000 to 2010.
*In 2009/10, a specific recommendation for vaccination against pandemic
influenza virus A (H1N1) 2009 was also issued, and included the
abovementioned groups (except elderly and residents of institutions) and also
healthy children under 12 years old, caretakers of infants under 6 months old,
and professionals performing core roles, according to priority groups.
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lected by random digit generation. All households re-
ceived a letter from INSA with an invitation to participate
in the ECOS panel and provide informed consent. Tele-
phone contact was then used to formalize participation
and record each household member’s demographic data.
The households included in each panel were renewed ap-
proximately every 3 years. The ECOS panel of families
was approved by the Portuguese Data Protection Author-
ity, which is in charge of ethical issues and protection of
individual data collection in Portugal.
The seasons included in the surveys were the winters
from 1998/99 to 2010/11, except for the winter of 2000/01.
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owing to lack of financing.
All surveys used the same questionnaire. The ques-
tionnaire was presented to one individual (≥18 years of
age) in each household using CATI (Computer Assisted
Telephone Interview) technology. This individual pro-
vided information on his/her vaccination status and in-
formation on the household. The terminology “percent
of vaccinated” used in reporting results refers to individ-
uals who reported being vaccinated or on which the re-
spondent said they were vaccinated.
The 1998/99, 1999/00, and 2001/02 surveys used the
sample set formed in 1998. The surveys from 2002/03 to
2005/06 were carried out with a sample that was se-
lected in 2002. The investigation in the 2006/07, 2007/08,
and 2008/09 seasons was conducted with a sample formed
in 2006. The 2009/10 and the 2010/11 surveys used a
sample that was selected in 2010 (Table 2).
A detailed description of the ECOS methodology can
be found in a published report [17]. Permission to use
the data for this study was obtained from the National
Institute of Health.
IV coverage was analyzed for the entire sample and for
specific groups defined by age and sex. Information on
demographic questions was collected during the initial
survey done at household recruitment time.
For the surveys conducted in 1998/99 to 2008/09, all
IV coverage estimates were adjusted by health region
using the 2001 Portuguese population census data (2001
Census data from the National Institute of Statistics).
For the surveys of the 2009/10 and 2010/11 periods that
were conducted using the dual sample frame, the IV
coverage estimates were adjusted by health region (Census
population 2001) and for cell phone and landline phone
coverage of Portuguese households using the methodology
described in Brick [18] and Kennedy [19]. WeightingTable 2 ECOS (Em Casa Observamos Saúde/Observing
Health at Home) samples survey completion dates
Survey/season Year ECOS sample formed Completion date
1998/1999 1998 May 1999
1999/2000 1998 February 2000
2001/2002 1998 July 2002
2002/2003 2002 May 2003
2003/2004 2002 March 2004
2004/2005 2002 April 2005
2005/2006 2002 May 2006
2006/2007 2006 February 2007
2007/2008 2006 February 2008
2008/2009 2006 January 2009
2009/2010 2010 April 2010
2010/2011 2010 February 2011factors were adjusted by post stratification for popula-
tion age and sex distribution.
To test the association (or independence) with disaggre-
gation variables, we used the modified F-statistics of the
second order adjustment of the Rao-Scott Chi-squared
test [20] whose properties are presented in Rao and
Thomas [21]. A 5% significance level was used for the
statistical tests, and the null hypothesis was rejected when
the probability of test significance (p-value) was <0.05.
We also calculated 95% confidence intervals for all
proportions.
We used a meta-regression model to test the linear
trend in IV coverage throughout the study period, and
the effect of the SARS, A (H5N1), and A (H1N1)2009
pandemics. Each survey estimate was weighted by the
inverse of the variance in the logit scale. The model fitted
to the logit of IV coverage included three dummy variables
(one for each event) and a sequence of numbers from 1 to
12 years to measure and test the time trend effect. The
model was adjusted to IV coverage in the general popula-
tion and age groups.
All analyses were performed using the statistical pro-
grams SPSS [22] or STATA SE [23].
Results
Study samples
Total sample sizes varied between the minimum value of
2192 individuals (2008/09) and the maximum value of
4167 individuals (2001/2002).
For sex distribution, there were no significant deviations
from the 2001 population census distribution (i.e., all
confidence intervals included the census population esti-
mates). There were small differences between the age
group distribution in the panel data and the population
age group distribution observed in the 2001 census. These
differences varied by year.
Influenza vaccine coverage from 1998/99 to 2010/11
Between 1998/99 and 2010/11, IV coverage in the Portuguese
general population (Table 3, Figure 1) varied between
14.2% (CI 95%: 11.6%–16.8%) and 17.5% (CI 95%: 17.6%–
21.6%).
The lowest vaccine uptake occurred in 1998/99 and
2006/07 (14.2%, CI 95%: 11.6%–16.8%; 14.3%, CI 95%:
13.0%–15.8%), and the highest vaccine uptake occurred in
the 2005/06 and 2009/10 seasons (19.1%, CI 95%: 17.4%–
20.9%; 19.5%, CI 95%: 17.6%–21.6%).
There was no trend in IV coverage of the general
population during the study period (p = 0.097).
Influenza vaccine coverage by sex and age group
Over all the studied seasons, there were no statistically
significant differences in IV coverage between women
and men. However, IV coverage was higher for women
Table 3 Influenza vaccine coverage in Portugal for the 1998/99 to the 2010/11 seasons
1998/99 1999/00 2001/02 2002/03 2003/04 2004/05 2005/06 2006/07 2007/08 2008/09 2009/10 2010/11
Total (n) n = 2923 n = 3796 n = 4148 n = 2715 n = 2598 n = 2525 n = 2206 n = 2630 n = 2537 n = 2192 n = 2809 n = 2684
Proportion
vaccinated (%) 14.2 15.6 17.0 15.0 18.4 15.4 19.1 14.3 16.0 18.3 19.5 17.5
(95% CI)
(11.6;
16.8)
(12.5;
18.7)
(14.5;
19.6)
(14.0;
16.0)
(16.7;
20.3)
(14.0;
17.0)
(17.4;
20.9)
(13.0;
15.8)
(14.5;
17.6)
(16.6;
20.1)
(17.6;
21.6)
(15.1;
20.3)
Notes: CI Confidence Interval; n sample size.
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ference between women and men was marginally sig-
nificant for the 2003/04 (p = 0.058) and the 2010/11
(p = 0.056) seasons.
Differences in IV coverage by age group occurred in
all seasons (Table 4, Figure 2). In the younger age group
(<15 years), a declining trend (with small fluctuations)
was present from 1999/00 to 2008/09 (p = 0.005). This
trend reversed in 2009/10, with one of the highest sea-
sonal IV coverages for this age group (12.9%, CI 95%:
9.3%–17.6%).
As expected, the highest IV coverage was observed in
individuals >65 years old. Between 1998/99 and 2010/11,
there was a gradual and significant increase in seasonal
IV coverage in the elderly (p for trend <0.001).
In the 1998/99 season, IV coverage was 31.3% (CI 95%:
26.1%–36.9%) and in the 2010/11 season it was 48.3%,
which was similar to the 50% coverage achieved in the
four previous seasons (Figure 2, Table 4).
An increasing trend was also identified in individuals
aged 45–64 years old (p for trend 0.035). A trend was not
present in the 15–44-year age group (p for trend 0.691).
Impact of major pandemic threats on seasonal influenza
vaccine coverage from 1998/99 to 2010/11
A meta-regression model was used to test for a potential
effect on IV coverage for the seasons 2003/04, 2005/06,
and 2009/10, while adjusting for the baseline vaccine14.2%
15.6%
17.0%
15.0%
18.4%
0%
5%
10%
15%
20%
25%
1998 1999 2000 2001 2002 2003 200
n.p.
Figure 1 Influenza vaccine coverage in Portugal. Notes: n.p. not performcoverage trend (Table 5). There was significantly higher
coverage in the general population for two seasons:
2003/04 (p = 0.032) and 2005/06 (p = 0.018). Coverage in
the 2009/10 season was not significant (p = 0.084).
Two coverage levels were significantly higher at the
5% confidence level: the IV uptake for the 45–64-year
age group in the 2005/06 season (p = 0.044), and the
vaccine uptake for the 0–14-year age group in the 2009/
10 season (p = 0.015).Discussion
Influenza vaccine coverage from 1998/99 to 2010/11
Between 1998/99 and 2010/11, IV coverage in Portugal
varied between 14.2% and 17.5%. There was no consist-
ent increase in percent IV uptake in the general popula-
tion (p for trend 0.097).
During this time period (Figure 1, Table 3), there were
four seasons that had notably higher IV coverage esti-
mates: 2003/04, 2005/06, 2008/09, and 2009/10. How-
ever, except for 2003/04, these seasons did not have the
highest coverage proportions in the elderly segment of
the population (≥65 years), for whom vaccination has
been long recommended. The seasonal IV coverage in-
crease in the general population was primarily due to
an increase in coverage in the 45–64-year age group
in the 2005/06 and 2008/09 seasons and to an increase in
the <15-year age group in the 2009/10 season (Table 4).15.4%
19.1%
14.3%
16.0%
18.3%
19.5%
17.5%
4 2005 2006 2007 2008 2009 2010
ed.
Table 4 Influenza vaccine coverage in Portugal for the 1998/99 to 2010/11 seasons, by sex and age
1998/99 1999/00 2001/02 2002/03 2003/04 2004/05 2005/06 2006/07 2007/08 2008/09 2009/10 2010/11
Sex (%) n = 1429 n = 1844 n = 1983 n = 1295 n = 1238 n = 1170 n = 1045 n = 1248 n = 1186 n = 1035 n = 1355 n = 1310
Male 13.9 15.5 16.9 15.0 16.6 14.8 19.2 13.0 14.9 16.7 19.1 15.9
(11.9; 16.3)* (13.6; 17.6) (15.0; 19.0) (12.7; 17.5) (14.3; 19.3) (12.8; 17.1) (16.7; 21.9) (11.1; 15.1) (12.9; 17.2) (14.5; 19.3) (16.4; 22.1) (13.1; 19.2)
n = 1424 n = 1952 n = 2165 n = 1420 n = 1360 n = 1295 n = 1161 n = 1382 n = 1351 n = 1157 n = 1454 n = 1374
Female 14.4 15.7 17.1 14.9 20.1 15.9 18.9 15.5 16.9 19.7 20.0 19.1
(12.3; 16.7) (13.9; 17.8) (15.3; 19.1) (12.8; 17.3) (17.7; 22.8) (13.9; 18.1) (16.7; 21.4) (13.6; 17.7) (14.9; 19.1) (17.3; 22.2) (17.2; 23.0) (16.1; 22.5)
p† 0.794 0.870 0.892 0.973 0.058 0.472 0.899 0.076 0.207 0.093 0.664 0.056
Age group (%) n = 390 n = 449 n = 481 n = 294 n = 290 n = 275 n = 214 n = 398 n = 352 n = 309 n = 457 n = 419
<15 12.1 14.6 10.2 5.7 8.2 6.1 11.3 4.4 3.9 5.5 12.9 9.6
(8.7; 16.6) (10.9; 19.1) (7.3; 14.0) (3.4; 9.4) (5.2; 12.8) (3.8; 9.7) (7.4; 16.7) (2.7; 7.0) (15.3; 21.9) (3.5; 8.8) (9.3; 17.6) (5.6; 16.3)
n = 1266 n = 1570 n = 1617 n = 960 n = 936 n = 835 n = 704 n = 982 n = 944 n = 772 n = 1184 n = 1090
15-44 9.9 8.1 9.5 6.6 7.6 4.3 7.7 6.1 7.8 8.3 10.3 7.4
(8.0; 12.1) (6.6; 9.8) (7.9; 11.4) (4.9; 8.8) (5.8; 9.8) (3.1; 5.9) (5.9; 10.2) (4.7; 7.9) (6.1; 9.8) (6.5; 10.6) (8.1; 12.9) (5.1; 10.5)
n = 818 n = 1066 n = 1244 n = 780 n = 810 n = 754 n = 707 n = 738 n = 776 n = 708 n = 800 n = 777
45 - 64 13.5 12.5 15.0 14.2 16.7 14.3 18.1 14.7 13.8 17.1 15.5 17.0
(10.9; 16.6) (10.3; 15.1) (12.8; 17.5) (11.4; 17.5) (13.8; 20.0) (11.8; 17.2) (15.2; 21.4) (12.2; 17.6) (11.4; 16.6) (14.3; 20.3) (12.4; 19.1) (13.5;21.2)
n = 433 n = 616 n = 716 n = 523 n = 561 n = 601 n = 514 n = 355 n = 431 n = 396 n = 368 n = 398
≥65 31.3 39.0 41.9 36.9 46.9 39.0 41.6 50.4 51.0 53.3 52.2 48.3
(26.1; 36.9) (34.3; 43.8) (37.6; 46.3) (31.9; 42.3) (41.9; 52.1) (34.9; 43.3) (37.1; 46.3) (44.8; 55.9) (45.8; 56.1) (47.9; 58.6) (45.6; 58.7) (40.9; 55.7)
p <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Notes: *95% confidence Interval; †p-value; n sample size.
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Figure 2 Influenza vaccine coverage in Portugal by age group. Notes: n.p. not performed.
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olescents were not recommended risk groups for IV
uptake in Portugal, except for during the 2009/10 influ-
enza pandemic. Therefore, seasonal IV coverage levels
among individuals <15 years old remained low. For most
of the seasons, it was <10%. There were four seasons
with slightly higher coverage levels in this age group: the
1998/99, 1999/00, 2005/06, and 2009/10 seasons, withTable 5 Inverse variance-weighted regression of vaccine cove
All
Variable Coef
Trend model Constant -1.75 ±
p<
Trend 0.02 ±
p=
Trend and awareness events model Constant -1.79 ±
p<
Trend 0.02 ±
p=
SARS 2003-2004 0.04 ±
p=
A (H1N5) 2005-2006 0.22 ±
p=
A (H1N1) 2009-2010 0.18 ±
p=
Notes: Coef.: inverse variance-weighted regression coefficients; SE: regression coefficcoverage point estimates of 12.1%, 14.6%, 11.3%, and
12.9%, respectively.
Children are not considered to be a risk group for sea-
sonal influenza. However, the general increased awareness
related to the A (H1N1)2009 pandemic, and specific rec-
ommendations from Portuguese health authorities to
vaccinate children may have affected seasonal vaccine
uptake. More investigation is needed to address thisrage in the general population and by age group
ages 0-14 15-44 45-64 65+
.±SE Coef.±SE Coef.±SE Coef.±SE Coef.±SE
0.09 -2.08 ± 0.29 -2.42 ± 0.16 -1.87 ± 0.08 -0.70 ± 0.01
0.001 p<0.001 p<0.001 p<0.001 p<0.001
0.01 -0.05 ± 0.04 -0.01 ± 0.02 -0.02 ± 0.01 -0.06 ± 0.01
0.097 p=0.210 p=0.609 p=0.035 p<0.001
0.08 -1.96 ± 0.25 -2.37 ± 0.17 -1.91 ± 0.08 -0.72 ± 0.11
0.001 p<0.001 p<0.001 p<0.001 p<0.001
0.01 -0.08 ± 0.03 -0.02 ± 0.02 0.02 ± 0.01 0.07 ± 0.01
0.106 p=0.012 p=0.320 p=0.037 p<0.001
0.10 0.04 ± 0.42 0.00 ± 0.28 0.17 ± 0.15 0.19 ± 0.17
0.032 p=0.930 p=0.999 p=0.044 p=0.256
0.09 0.56 ± 0.42 0.06 ± 0.28 0.23 ± 0.11 -0.15 ± 0.17
0.018 p=0.180 p=0.833 p=0.044 p=0.368
0.11 1.04 ± 0.43 0.47 ± 0.30 -0.04 ± 0.15 0.01 ± 0.23
0.084 p=0.015 p=0.116 p=0.783 p=0.954
ients standard error; p-value tests the significance of regression coefficients.
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ticularly strong considering that elevated vaccine uptake
in season 2009/10 was not significantly higher than the
other three seasons.
Individuals >65 years old had the highest coverage
in all seasons. Values ranged from 31.3% in 1998/99 to
53.3% in the 2008/09 season (point estimates).
Regarding the 12-year pattern, a statistically significant
increasing trend (p < 0.001) was observed for IV cover-
age in Portugal since 1998 in the elderly. However, after
50% coverage was achieved in 2006/07, a plateau was
reached and no further improvement was observed in
the last 4 years of the study period. The 2009 pandemic
did not affect seasonal vaccination coverage in the eld-
erly population in Portugal. Coverage was around 50%,
which was similar to the three previous periods. This re-
sult is consistent with the fact that seasonal vaccine rec-
ommendations did not change throughout this period.
Unchanged seasonal coverage rates were also observed
in an elderly population in France [24].
In Europe, estimates for IV coverage in the elderly
indicate that some countries failed to meet the target
of 50% coverage in 2006. Portugal was not one of
these countries [25]. However, other countries achieved
the 75% coverage target for 2010. These countries were
England, Scotland, Wales (79% in the 2005/06 season)
[25], and The Netherlands (74% CI 95%: 71%–77% in
2001/02) [26]. A recent study of 11 European countries
(2006/07 season) found that Spain, with 71% coverage,
was close to meeting the goal [27]. This study also esti-
mated that there was 53% IV coverage in Portugal for indi-
viduals ≥65 years, which is consistent with the estimate
obtained in our study (50.4%, CI 95%: 44.8%–55, 9%). Com-
pared with the other 10 countries included in the study
(United Kingdom, Germany, Italy, France, Spain, Austria,
Czech Republic, Ireland, Finland, and Poland), IV coverage
in the elderly (≥ 65 years) in Portugal was sixth, but was
similar to the overall estimate for all countries (53.2%).
In another European study that included 22 European
countries (2006/07 season), Portugal ranked thirteenth
for IV coverage in the elderly, and represented the me-
dian value for coverage in Europe [28]. This finding was
consistent with the findings of the previous study.
Given that the elderly had been targeted for vaccin-
ation for many years and are the largest risk group, these
results indicate that progress has been made toward
meeting the WHO coverage goals. They reflect positively
on Portuguese vaccination policies. Nevertheless, the
2010 75% coverage goal for 2010 remained far from be-
ing achieved. The 50% coverage plateau since 2006/07 in-
dicates that additional effort is needed to further improve
vaccination levels. Receiving advice from the family doc-
tor/nurse has been identified as the main motivation to
get vaccinated among the Portuguese population [29],followed (at a considerable distance) by old age as a rea-
son. This result suggests that efforts directed at family
doctors could have the greatest effect on IV uptake in the
elderly. Public information campaigns that are directed at
risk groups may also have an effect.
Effect of major pandemic threats on influenza vaccine
coverage from 1998/99 to 2010/11
We hypothesized that 2003/04, 2005/06, and 2009/10
were seasons during which there was special awareness
about vaccination among the general Portuguese popula-
tion, and/or among subgroups defined by age. We used a
meta-regression model to test this hypothesis. These sea-
sons were selected based on major public health threats
worldwide: SARS in 2003/04, the increase in H5N1 virus
infections in humans in Southeast Asia in 2005/06, and
the declaration of an influenza pandemic in 2009/10.
Global and national health authorities, and the medical
community worldwide, reinforced flu vaccination recom-
mendations in 2003/04 [30]. In 2005/06, the pandemic
threat, with associated vaccination recommendations, led
to news and opinions that circulated in the medical com-
munity and in the general population. This news coverage
could have led to an increased demand for the influenza
vaccine. In fact, in a study on IV coverage in Germany
(2001–2006), the authors found that coverage increased
during the 2005/06 season. They suggested that the greater
media focus on pandemic influenza was one factor that ex-
plained the increased vaccine demand [31].
In 2009/2010, the declaration of a worldwide influenza
pandemic by WHO focused the attention of the media
on influenza. Health ministries worldwide, including in
Portugal, issued broad guidance to health services that
was also reported by the media.
The results of the meta-regression model (Table 5) indi-
cate that in the general population, influenza coverage was
significantly greater in two seasons, 2003/2004 (p = 0.032)
and 2005/2006 (p = 0.018). The seasonal influenza cover-
age in the general population during the 2009/2010 season
was not significantly greater (p = 0.084). However, an
examination of IV coverage differences for these three
seasons, according to the age group, revealed that two
coverage estimates were significant: the increase in vac-
cine uptake of the 45–64 segment of the population in the
2005/06 season (p = 0.044) and the increase in IV uptake
in the 0–14 group in the 2009/10 season (p = 0.015).
These findings indicate that when accounting for the
baseline trend, there was an increase in IV coverage dur-
ing the 2003/04 and 2005/06 seasons, which suggests
that awareness about vaccination could have increased
in the general population and in specific age groups.
Although the 12.9% coverage in children was not the
highest of all the seasons was still an important increase.
Risk perception regarding flu in children may have
Pinto et al. BMC Public Health 2013, 13:1130 Page 9 of 10
http://www.biomedcentral.com/1471-2458/13/1130increased during the 2009/10 season, and pandemic
awareness and special recommendations for children to
be vaccinated during the pandemic could have affected
seasonal vaccine uptake in Portugal in the 2009/10 sea-
son in this group.
Risk perception affects vaccine uptake [32,33]. Al-
though results vary in degree and direction, perceptions
about the risk of disease and severity of infection that
follow major pandemic threats may affect uptake of sea-
sonal influenza vaccine [33-35]. The results of our study
suggest that these events may have had a positive effect
on IV uptake in Portugal. More research is needed to
understand the factors underlying an individual’s deci-
sion to be vaccinated against influenza.
Limitation of the study
ECOS is a sample of families from mainland Portugal,
with landline and mobile telephones, who agree to
complete periodic health surveys. Residents of Portugal
who do not have a landline or mobile telephone were
not represented in this study.
Between 1998/1999 and 2010/2011, the ECOS panel
sample was renewed three times (2002, 2006, and 2010).
Therefore, the estimates of IV coverage were obtained
using four different samples that were selected using the
same methodology. Using the same sample for more
than one consecutive season could lead to biased cover-
age estimates. Specifically, the application of the ques-
tionnaire to the same sample in two consecutive seasons
could lead to a greater proportion of individuals who
choose to be vaccinated the next season. This change in
behavior could artificially increase IV coverage, which
would not represent coverage in the general population.
There is no evidence of this bias in our study, because in
each population group, IV coverage increase was not
consistent or systematic for the four periods between
changes in the sample population (1998 to 2001, 2002 to
2005, 2006 to 2009, and 2010 to the present).
As previously described, the representativeness of the
samples studied in comparison with estimates from the
2001 census of the Portuguese mainland population
found age deviations from this reference population.
These deviations could be translated into an IV coverage
bias in the general population. However, in risk groups
for whom vaccination is recommended, particularly the
elderly (≥ 65 years), and for whom IV coverage monitor-
ing is more critical for control measures, the age bias
presented by our samples was less relevant.
Recall bias may occur when individual recall of infor-
mation is used to obtain data. However, individuals were
vaccinated some months before each survey and this
time differed from survey to survey. Additionally, only
one individual (>18 years) per household answered ques-
tions about vaccination status of household members.Surveying all of the individuals in a household would
make the procedure more complex and could lead to a
failure of the entire process, which occurred during pre-
vious surveys using the ECOS panel [17].
Conclusions
From 1998/99 to 2010/11, seasonal IV coverage in
Portugal varied between 14.2% and 17.5%. No significant
increasing trend was observed in the Portuguese general
population during this period.
There was a clear, increasing trend in IV coverage in the
elderly population (p < 0.001). Coverage increased from
31.3% in 1998/99 to 48.3% in 2010/11. After 2006/07,
however, IV coverage in the elderly has remained near
50%, which suggests that there has been a slowdown in
the growth trend. Thus, in 2010, the 75% WHO target in
this major risk group had not been met. This result indi-
cates that there is a need to improve the influenza vaccin-
ation strategy in Portugal to comply with the ambitious
coverage goals proposed by WHO.
The major pandemic threats of the last decade had an
effect on seasonal influenza vaccination. There was a sig-
nificant increase in vaccine uptake in the general popu-
lation in 2003/04 (p = 0.032) and in 2005/06 (p = 0.018).
The 2009/10 seasonal vaccine coverage in the general
population was not significantly higher when accounting
for the baseline trend, but the 12.9% of vaccination oc-
curred in individuals <15 years old. Although not the
highest of all the seasons, this result was significant
when accounting for vaccination trend in this age group
during the past decade.
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